NCT04243681View on ClinicalTrials.gov

Combination of Autologous MSC and HSC Infusion in Patients With Decompensated Cirrhosis

PHASE4CompletedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

July 1, 2019

Primary Completion Date

August 1, 2020

Study Completion Date

September 1, 2020

Conditions
Cirrhosis, Liver
Interventions
COMBINATION_PRODUCT

CD 34 and MSC infusion

Combination of stem cells

DRUG

Standard of care for Cirrhosis management

Drugs used for Cirrhosis management such as Diuretics, Hepatoprotective agents and Lactulose

Trial Locations (1)

500032

Asian Institute Of Gastroenterology, Hyderabad

All Listed Sponsors
lead

Asian Institute of Gastroenterology, India

OTHER

NCT04243681 - Combination of Autologous MSC and HSC Infusion in Patients With Decompensated Cirrhosis | Biotech Hunter | Biotech Hunter